We are proud to announce that the European Regional Development Fund (EFRE) funds the realization of the imuStain project at imusyn.
As of March 2018, our recombinant blood group antigens (rBGA) and DaraEx can be purchased from inno-train Diagnostik GmbH.
We have developed a new, patent-pending remedy for anti-CD38 antibody interference in immunohematological pre-transfusion testing, called "DaraEx".
EN ISO 13485:2016, issued June 17th, 2020
|ISO 13485:2016 Certificate|